XML 34 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows Statement (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Dec. 31, 2011
Dec. 31, 2010
OPERATING ACTIVITIES:    
Net loss $ (186,709) $ (92,042)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 7,983 8,609
Amortization of licenses and software development(1) 250,621 [1] 191,168 [1]
Loss on disposal of property and equipment 225 18
Restructuring charges 5,462 147
Changes in deferred net revenue and related expenses 24,486 11,503
Amortization of debt issuance costs 187 589
Amortization of interest 0 808
Gain on investments (248) (2,807)
Stock-based compensation(2) 4,653 [2] 7,098 [2]
Changes in operating assets and liabilities:    
Accounts receivable, net of allowances 7,254 (53,713)
Inventory 4,564 (9,269)
Licenses (22,183) (55,954)
Software development (135,005) (173,526)
Prepaid expenses and other current assets 2,359 (4,485)
Accounts payable 16,834 29,055
Accrued and other liabilities (6,677) (28,298)
Income taxes (1,529) 3,679
Net cash used in operating activities (27,723) (167,420)
INVESTING ACTIVITIES:    
Proceeds from sales and maturities of available-for-sale investments 0 149,915
Proceeds from sales and maturities of trading investments 0 22,775
Purchases of available-for-sale investments 0 (64,781)
Other long-term assets 1,224 (473)
Purchases of property and equipment (6,237) (10,467)
Net cash provided by (used in) investing activities (5,013) 96,969
FINANCING ACTIVITIES:    
Proceeds from issuance of common stock to employees 21 777
Payment of debt issuance costs (1,264) 0
Borrowings on secured credit line 52,000 0
Payment of secured credit line (52,000) (13,249)
Net cash used in financing activities (1,243) (12,472)
Effect of exchange rate changes on cash (3,939) 3,944
Net decrease in cash and cash equivalents (37,918) (78,979)
Cash and cash equivalents - beginning of period 85,603 188,378
Cash and cash equivalents - end of period $ 47,685 $ 109,399
[1] Excludes amortization of capitalized stock-based compensation expense.
[2] Includes the net effects of capitalization and amortization of stock-based compensation expense.